臨床症状
Tamlyn J Watermeyer1,2,3, Joe Butler4,5, Samuel O Danso6,7
1Edinburgh Dementia Prevention, Centre for Clinical Brain Sciences, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
まとめ
新しいデジタル視覚短期記憶結合(dVSTMB)タスクは、ダウン症候群(DS)の成人におけるアルツハイマー病(AD)の早期検出に有望であることが示されている。dVSTMBは実行可能で許容でき、一部の参加者はADを示唆する基準を満たしている。
科学分野:
- 神経科学;心理学;遺伝学
背景:
- ダウン症候群(DS)の成人には、早期発症アルツハイマー病(AD)のリスクが著しく高くなっています。;現在の神経心理学的ツールは、DS集団における早期AD検出の感度が低く、研究参加を妨げています。;視覚短期記憶結合(VSTMB)タスクによって評価される共役記憶結合は、AD病理の早期指標です。
研究 の 目的:
- DSの個人向けに調整された新しいデジタルVSTMB(dVSTMB)の実行可能性、許容性、および識別能力を評価すること。;DS集団におけるADの早期検出のための敏感なツールとしてのdVSTMBの可能性を評価すること。
主な方法:
- 17人のDS参加者がdVSTMBとHorizon 21アルツハイマー病(H21AD)バッテリーを完了しました。;ベイズのペアサンプルt検定を使用して、dVSTMBの形状のみの条件と色結合条件間のパフォーマンスを比較しました。;参加者は、結合コストスコア(BCS)基準に基づいて、「弱い」または「強い」バインダーに分類されました。
主要な成果:
- dVSTMBの完了率は82.4%でした。完了できなかったのは、指示の難しさによるもので、脱落ではありません。;話さない参加者は、一部のH21-AD項目とは異なり、dVSTMBを無事に完了しました。;dVSTMBは高い満足度評価(M=6.33)が報告され、参加者は形状のみの条件(BF+0=44.28)でより良い成績を収めました。
結論:
- dVSTMBは、DSの個人にとって初期の実行可能性と許容性を示しています。;一部の参加者はADを示唆するBCS基準を満たしており、この集団におけるADスクリーニングの可能性を示しています。;タスク指示のさらなる監視と、他の学習障害グループへの拡大が計画されています。
関連する概念動画
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management
652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437


